Evaluation of treatment response and resistance in metastatic renal cell cancer using integrated positron emission tomography/magnetic resonance imaging (PET/MRI) with 18F-Fluorodeoxyglucose (FDG): The REMAP study

Project: Research

Project Details

Effective start/end date1/09/201531/08/2018

Collaborative partners

  • King's College London (lead)
  • GSTT Guy's and St Thomas' NHS Foundation Trust
  • University of Birmingham
  • Mount Vernon Hospital


  • CRUK Cancer Research UK: £311,327.00